Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy Guidelines Pocket Guide - Guideline Central

Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy

American Society of Clinical OncologyPublished: November 1, 2021

A PDF version of this Pocket Guide is also available!
$21.95
  • Key Points
  • Key Recommendations
  • Tables
    • Immunosuppressive Agents
    • Commonly Conducted Testing at Baseline Prior to ICPi Therapy
    • Commonly Conducted Testing During irAE Management With Steroids
    • Cutaneous Toxicities
    • Gastointestinal Toxicities
    • Lung Toxicities
    • Endocrine Toxicities
    • Musculoskeletal Toxicities
    • Renal Toxicities
    • Nervous System Toxicities
    • Hematologic Toxicities
    • Cardiovascular Toxicities
    • Ocular Toxicities
    • Systemic Toxicities
    • Prevention and Management of Adverse Events Related to Steroid Use


You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.